2-203936854-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012092.4(ICOS):​c.40C>T​(p.Arg14Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00135 in 1,610,374 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R14H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0073 ( 15 hom., cov: 32)
Exomes 𝑓: 0.00073 ( 13 hom. )

Consequence

ICOS
NM_012092.4 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.89

Publications

3 publications found
Variant links:
Genes affected
ICOS (HGNC:5351): (inducible T cell costimulator) The protein encoded by this gene belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation. [provided by RefSeq, Jul 2008]
ICOS Gene-Disease associations (from GenCC):
  • common variable immunodeficiency
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • immunodeficiency, common variable, 1
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035465658).
BP6
Variant 2-203936854-C-T is Benign according to our data. Variant chr2-203936854-C-T is described in ClinVar as [Benign]. Clinvar id is 439812.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00732 (1114/152102) while in subpopulation AFR AF = 0.0257 (1066/41474). AF 95% confidence interval is 0.0244. There are 15 homozygotes in GnomAd4. There are 508 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ICOSNM_012092.4 linkc.40C>T p.Arg14Cys missense_variant Exon 1 of 5 ENST00000316386.11 NP_036224.1 Q9Y6W8-1Q53QY6
ICOSXR_007073112.1 linkn.92C>T non_coding_transcript_exon_variant Exon 1 of 6
LOC101927840XR_427213.4 linkn.314+463G>A intron_variant Intron 2 of 3
ICOSXM_047444022.1 linkc.-3581C>T upstream_gene_variant XP_047299978.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ICOSENST00000316386.11 linkc.40C>T p.Arg14Cys missense_variant Exon 1 of 5 1 NM_012092.4 ENSP00000319476.6 Q9Y6W8-1
ICOSENST00000435193.1 linkc.40C>T p.Arg14Cys missense_variant Exon 1 of 4 1 ENSP00000415951.1 Q9Y6W8-2
ENSG00000300710ENST00000773540.1 linkn.183+463G>A intron_variant Intron 2 of 3

Frequencies

GnomAD3 genomes
AF:
0.00732
AC:
1113
AN:
151982
Hom.:
15
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0257
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00194
AC:
488
AN:
250972
AF XY:
0.00148
show subpopulations
Gnomad AFR exome
AF:
0.0275
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000726
AC:
1059
AN:
1458272
Hom.:
13
Cov.:
29
AF XY:
0.000620
AC XY:
450
AN XY:
725690
show subpopulations
African (AFR)
AF:
0.0270
AC:
903
AN:
33398
American (AMR)
AF:
0.00127
AC:
57
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86194
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52844
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000261
AC:
29
AN:
1109262
Other (OTH)
AF:
0.00109
AC:
66
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
56
112
169
225
281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00732
AC:
1114
AN:
152102
Hom.:
15
Cov.:
32
AF XY:
0.00683
AC XY:
508
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.0257
AC:
1066
AN:
41474
American (AMR)
AF:
0.00210
AC:
32
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10564
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68000
Other (OTH)
AF:
0.00427
AC:
9
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
51
102
152
203
254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00229
Hom.:
9
Bravo
AF:
0.00824
ESP6500AA
AF:
0.0266
AC:
117
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00241
AC:
292
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 13, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Immunodeficiency, common variable, 1 Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ICOS-related disorder Benign:1
Dec 22, 2023
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.54
CADD
Uncertain
25
DANN
Benign
0.87
DEOGEN2
Benign
0.35
T;.
Eigen
Benign
-0.061
Eigen_PC
Benign
0.088
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.70
T;T
MetaRNN
Benign
0.0035
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;N
PhyloP100
3.9
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.9
N;N
REVEL
Benign
0.12
Sift
Uncertain
0.019
D;D
Sift4G
Uncertain
0.020
D;D
Polyphen
0.39
B;P
Vest4
0.22
MVP
0.45
MPC
0.47
ClinPred
0.024
T
GERP RS
5.6
PromoterAI
-0.015
Neutral
Varity_R
0.11
gMVP
0.85
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77411896; hg19: chr2-204801577; API